Jamey Millar
business executiveMale0.0Global Dominance: 0.00%
Jamey Millar is the newly appointed head of operations for Novo Nordisk in the United States, recently in the news for announcing significant price reductions on the company's leading obesity treatment, Wegovy, and diabetes medication, Ozempic, in an effort to improve access for millions affected by obesity and Type 2 diabetes.
Power0
Reach0
Collect
Not in the pool (under ¢1).
Recent news mentions
Jamey Millar stressed the overall health benefits of Wegovy, including lower risk of cardiovascular problems.
Medicare will start covering weight-loss drugs on July 1 for the first time. Here’s what you need to knowCNN·
United States· 2026-06-29
United States· 2026-06-29
Jamey Millar is the new head of operations for Novo Nordisk in the United States.
Traitements antiobésité : Novo Nordisk, sous pression aux Etats-Unis, contre-attaque sur les prixLe Monde·
France· 2026-02-25
France· 2026-02-25